World's First FDA IDE Coronary Patient Treated With a DEB - 11 July 2020 10:00

NYON, Switzerland, July 11, 2020 /PRNewswire-AsiaNet/ -- MedAlliance has announced enrollment of the first patient in its study of SELUTION SLR(TM) 014 DEB (http://medalliance.com/product/ )for the treatment of In-Stent Restenosis (ISR). This is the first DEB accepted by the FDA for its 'Breakthroug...

  Merck Opens its Largest M Lab(TM) Collaboration Center in Shan... - 10 July 2020 15:00

DARMSTADT, Germany, July 10, 2020 /PRNewswire-AsiaNet/ -- -- Focus on improving and optimizing drug discovery, development and manufacturing -- Integrated lab with customizable solutions, validation services, training and hands-on applications -- Shanghai center is newest and largest addition to Merck'...

  Laboratory Studies Confirm BETADINE(R) Antiseptic Products' Ef... - 10 July 2020 00:10

SINGAPORE, July 9, 2020 /PRNewswire-AsiaNet/ -- Study published in Infectious Disease and Therapy Journal Mundipharma today announced that laboratory testing at the Duke-NUS Medical School in Singapore, has confirmed the effectiveness of its BETADINE(R) antiseptic products against the novel...

  Rapidly Changing Behaviours In 2020 Are Accelerating Consumer ... - 08 July 2020 19:29

NEW YORK, July 8, 2020 /PRNewswire-AsiaNet/ -- - 45% of global consumers say healthcare is one of the top three reasons for living in a city - 69% of global consumers are more focused on mental health and well being - 43% of global consumer expect businesses to be accountable for their env...

  Evive Biotech meets primary and secondary endpoints in global ... - 08 July 2020 11:00

SHANGHAI, July 8, 2020 /PRNewswire-AsiaNet/-- --Safety and efficacy endpoints met successfully in pivotal trial for F-627 (efbemalenograstim alfa), a novel long-acting G-CSF --Key milestone and validation for Evive's novel biologic development capability and technology platform --Key comp...

  Premium Passports Lose Their Shine in a Post-pandemic World - 07 July 2020 18:00

LONDON, July 7, 2020, /PRNewswire-AsiaNet/-- As parts of the globe cautiously begin to open up, the focus is on what travel freedom and global mobility will look like in a post–Covid-19 world. Last week the EU released a list of countries that would be allowed entry into the bloc from 1 July...

  Australians concerned about return to pre-pandemic life and ec... - 06 July 2020 08:11

MELBOURNE, Australia, July 6, 2020 /PRNewswire-AsiaNet/ -- - Morneau Shepell's Mental Health Index(TM) improves slightly for June with a 12-point decline from the pre-pandemic benchmark of 75 Morneau Shepell, a leading provider of total wellbeing, mental health and digital mental health services, today...

  Apollo Proton Cancer Centre Receives Prestigious JCI Accredita... - 04 July 2020 00:57

CHENNAI, India, July 3 /PRNewswire-AsiaNet/-- Apollo Proton Cancer Centre (APCC), the first Proton Therapy Centre in South Asia and the Middle East, announced its accreditation by Joint Commission International (JCI), the recognized global leader in health care accreditation. This makes A...

  Xovis Multiplies Your Options in One Fell Swoop - 02 July 2020 23:42

ZOLLIKOFEN, Switzerland, July 2, 2020 /PRNewswire-AsiaNet/ -- - Two new AI features for in-store analytics made possible by Xovis 3D sensors When their ordinary "all-in-a-day's-work" became extraordinary, Xovis ramped up their R&D to solve unforeseen challenges. Today, the company proudly presents two new...

  HeiQ Viroblock Certified as Cosmetic Grade and Bio-based Renew... - 02 July 2020 19:00

ZURICH, July 2, 2020 /PRNewswire-AsiaNet/ -- Textile innovator HeiQ's antiviral textile technology, HeiQ Viroblock NPJ03, has been certified as safe and sustainable as all its ingredients are cosmetic grade, bio-based, and recycled. Leading the international textile industry to fight the ...